Merck, B0274-10TAB, 5-Bromo-4-chloro-3-indolyl phosphate p-toluidine salt

Name: 5-Bromo-4-chloro-3-indolyl phosphate p-toluidine salt
Brand: Merck
SKU: B0274-10TAB

Size:10 tabs, BCIP® p-toluidine salt, X-phosphate p-toluidine salt, tablet

Available Catalog Numbers

B0274-10TAB B0274-25TAB

Catalog Number: B0274-10TAB

Pricing

Send an RFQ.

View RFQ List

Category

ELISA Substrates

TagsProtein Biology Proteins & Enzymes Detection Substrates & Enzymes

CollectionsMerck Proteins & Enzymes: Nucleases, Albumins & High‑Purity Enzymes Merck Cell Culture Supplements & Reagents: Complete Solutions for Research & Bioproduction Merck Roche Life Science Products for PCR, RT‑PCR & Nucleic Acid Purification

Description

General description
Histochemical substrate for alkaline phosphatase.
Application
For the colorimetric detection of alkaline phosphatase-labeled molecules, 5-Bromo-4-chloro-3-indolyl phosphate (BCIP) and Nitro Blue Tetrazolium (NBT) are available. The BCIP/NBT substrate system is versatile and functions in a variety of applications, including Northern Southern, and Western blotting, in situ hybridization, and immunohistochemistry.
BCIP is provided in two salt forms: the disodium salt which is soluble in water and the p-toluidine form which is soluble in dimethylformamide. These salt forms may be used to prepare a stock solution that in combination with NBT and a reaction buffer, form a substrate solution for alkaline phosphatase. This substrate system, when incubated with alkaline phosphatase, produces an insoluble NBT diformazan product that is easily observable with its purple color. For added convenience, a mixture of BCIP and NBT is provided in an easily dissolvable tablet form or as a ready-to-use liquid.
For the colorimetric detection of alkaline phosphatase-labeled molecules.
Biochem/physiol Actions
Substrate of choice for use with alkaline phosphatase in immunoblotting and, less commonly, in immunohistological staining procedures. High assay sensitivity is achieved via amplification when BCIP is used in conjunction with Nitro Blue Tetrazolium (NBT) Tablets (Catalog No. N5514). This substrate produces an insoluble end product that is blue-purple in color and can be observed visually.
Preparation Note
Contains 25 mg substrate per tablet.
Legal Information
BCIP is a registered trademark of Merck KGaA, Darmstadt, Germany

Specifications

General

NACRES	NA.83
PubChem Substance ID	57653906
UNSPSC Code	12352204
EC Number	229-506-1
MDL number	MFCD00040636
InChI key	QEIFSLUFHRCVQL-UHFFFAOYSA-N
InChI	1S/C8H6BrClNO4P.C7H9N/c9-4-1-2-5-7(8(4)10)6(3-11-5)15-16(12,13)14;1-6-2-4-7(8)5-3-6/h1-3,11H,(H2,12,13,14);2-5H,8H2,1H3
SMILES string	Cc1ccc(N)cc1.OP(O)(=O)Oc2c[nH]c3ccc(Br)c(Cl)c23
form	tablet
storage temp.	−20°C
Quality Level	200

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.